Sensipar Antitrust Claims Trimmed In Amgen, Teva MDL
The Delaware federal judge charged with overseeing sprawling multidistrict litigation accusing Amgen and Teva Pharmaceuticals, among others, of hatching an illegal deal to remove a generic calcium control drug off the...To view the full article, register now.
Already a subscriber? Click here to view full article